Shelley Chu

Shelley Chu

Directeur/Membre du Conseil chez ODYSSEY THERAPEUTICS, INC.

Fortune : 188 998 $ au 31/05/2026

56 ans
Health Technology
Finance
Commercial Services

Profil

Shelley Chu is currently an Independent Director at Odyssey Therapeutics, Inc. since 2025.
Current roles also include Director positions at Alpha-9 Oncology, Inc., Diagonal Therapeutics, Inc., Zag Bio, Inc., SFJ Pharmaceuticals, Inc., Antares Therapeutics, Inc., 3T Biosciences, Inc., ImmunOs Therapeutics AG, Adanate, Inc., Q32 Bio Operations, Inc., Protego Biopharma, Inc., IFM Cinque, Inc., IFM Continua, Inc., IFM Quattro, Inc., TRIANA Biomedicines, Inc., Medikine, Inc., Trishula Therapeutics, Inc., Enlaza Therapeutics, Inc., Ifm Therapeutics, Inc., Abata Therapeutics, Inc., IFM Due, Inc., and Seismic Therapeutic, Inc. since 2022.
A Partner at Lightspeed Management Co LLC since 2020.
Former roles include Director at Kalidex Pharmaceuticals, Inc., Venatorx Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Tizona Therapeutics, Inc., Phathom Pharmaceuticals, Inc., Novartis Inflammasome Research, Inc., and Partner at Abingworth LLP and Abingworth Management, Inc. Senior Director-R&D Strategy at Gilead Pharmasset LLC from 2012 to 2015.
Independent Director at HilleVax, Inc. from 2021 to 2025.
Principal at Frazier Management LLC and Flagship Pioneering, Inc. from 2002 to 2005.
Education includes undergraduate studies at Princeton University and a doctorate from The University of California, San Francisco.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
11/05/2026 11 111 ( 0,02 % ) 188 998 $ 31/05/2026

Postes actifs de Shelley Chu

SociétésPosteDébut
ODYSSEY THERAPEUTICS, INC. Directeur/Membre du Conseil 01/08/2025
Directeur/Membre du Conseil 10/02/2022
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Shelley Chu

SociétésPosteFin
HILLEVAX, INC. Directeur/Membre du Conseil 17/09/2025
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ -
Voir l'expérience en détail de Shelley Chu

Formation de Shelley Chu

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

38

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Finance

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

  1. Bourse
  2. Insiders
  3. Shelley Chu
🔇